论文部分内容阅读
国家“九五”攻关课题--血脂康调整血脂对冠心病二级预防的研究”,近日通过国家验收。这一课题的完成,意味着我们向世界推出了中国人的“天然他汀”,使中国在世界调脂药领域占有了一席之地。大量流行病学资料表明,血脂异常是冠心病的一个重要的独立危险因素。国外循证医学证据
The National “Ninth Five-Year Plan” research topic - Xuezhikang’s research on the adjustment of blood lipids to secondary prevention of coronary heart disease“ has recently passed national acceptance. The completion of this topic means that we have introduced the Chinese people’s ”natural statins" to the world. China has occupied a place in the field of lipid-regulating drugs in the world, and a large number of epidemiological data indicate that dyslipidemia is an important independent risk factor for coronary heart disease.